The role of etretinate (Tegison; Tigason) in the management of keratoacanthoma.
Four patients with keratoacanthomas 2 to 3 cm in size were treated with etretinate. All the patients demonstrated early response and complete regression of the lesions. Follow-up (of 24 months in one case) did not reveal any recurrence.
D000368:Aged; D001706:Biopsy; D005050:Etretinate / Q000627:therapeutic use*; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D007636:Keratoacanthoma / Q000188:drug therapy* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D012867:Skin / Q000473:pathology
D005050:Etretinate